Finance

Lists
BDSX:NASDAQ
Biodesix Inc
$26.48
-2.52%
(-0.68) 1D
$26.48
0.00% (0.00)
After hours
Closed: Sep 3, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDSX...
Open
$27.29
High
$27.29
Low
$25.95
Mkt. cap
279.34M
Avg. vol.
114.91K
Volume
0.00
52-wk high
$31.31
52-wk low
$5.26
EPS
-$3.17
Beta
0.60
Shares outstanding
10.55M
No. of employees
334
Open
$27.29
High
$27.29
Low
$25.95
Mkt. cap
279.34M
Avg. vol.
114.91K
Volume
0.00
52-wk high
$31.31
52-wk low
$5.26
EPS
-$3.17
Beta
0.60
Shares outstanding
10.55M
No. of employees
334
News stories
From web sources and news partners
About Biodesix Inc
CEO-
Employees334
Founded2005
HeadquartersLouisville, Colorado, United States
SectorHealth care provider
Websitebiodesix.com
Analyst ratings
Based on 6 analysts giving stock ratings to BDSX in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for BDSX in the last 3 months.
Highest
Current $26.48
$40.00 (+51.09%)
Average
$32.80 (+23.89%)
Lowest
$27.00 (+1.98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
$35.00
+32.2%
08/10/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
$30.00
+13.3%
08/06/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$27.00
+2%
08/07/2026
William Bonello
Craig-Hallum
Buy
Maintained
$40.00
+51.1%
08/06/2026
Max Masucci
Roth MKM
Buy
Maintained
$32.00
+20.9%
08/06/2026
Matt Larew
William Blair
Buy
Reiterated
-
-
08/06/2026
Unknown Analyst
Roth MKM
Buy
Initiated
$32.00
+20.9%
06/24/2026
Thomas Flaten
Lake Street
Buy
Maintained
$40.00
+51.1%
05/05/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
21.77M
28.76M
25.56M
26.86M
Cost of goods sold
4.11M
4.88M
4.60M
4.82M
Cost of revenue
4.11M
4.88M
4.60M
4.82M
Research and development expenses
2.99M
2.87M
3.28M
3.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.71M
22.97M
24.26M
24.28M
Operating expense
24.71M
25.84M
27.55M
27.42M
Total operating expenses
28.81M
30.72M
32.15M
32.24M
Operating income
-7.04M
-1.97M
-6.60M
-5.38M
Other non operating income
409.00K
46.00K
385.00K
-
EBT including unusual items
-8.72M
-3.98M
-7.79M
-7.27M
EBT excluding unusual items
-8.71M
-3.98M
-8.19M
-7.26M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.72M
-3.98M
-7.79M
-7.27M
Net profit margin
-40.04%
-13.84%
-30.50%
-27.08%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
97.00K
Interest expense
-2.07M
-2.06M
-1.98M
-1.98M
Net interest expenses
-2.07M
-2.06M
-1.98M
-1.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.64M
-579.00K
-5.20M
-3.99M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps